Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

SRNE

Sorrento Therapeutics, Inc.

USD

Set alert

Price alert · SRNE

All alert types
0.00 USD 0.00 0.00%
As of Oct 30, 2026
0.009 Day range 0.01
0.0001 52-week range 0.009
YTD
-88.46%
1 year
-96.05%
Open
0.009
Prev close
0.0003
Mkt cap
165.38K
Vol
501.68K
Avg vol
80.52K
EPS
-0.67
P/E
0.00
Div yield
0.00%
More statistics
Low
0.009
High
0.01
Forward P/E
-0.45
Beta
0.00
Dividend
0.00
Ex-div date
Earnings
Oct 4, 2024
50-d avg
0.817524
200-d avg
1.58
1y target
13.00

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for SRNE has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-10.88 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.0×
FY 2013: -0.1×FY 2014: -0.1×FY 2015: -0.1×FY 2016: -0.0×FY 2017: 0.3×FY 2018: -0.0×FY 2019: -0.0×FY 2020: -0.1×FY 2021: -0.0×FY 2022: -0.0×
FY 2013 5y median -0.0× FY 2022
P/S 0.1×
FY 2013: 2.6×FY 2014: 0.7×FY 2015: 0.7×FY 2016: 0.3×FY 2017: 0.0×FY 2018: 0.1×FY 2019: 0.2×FY 2020: 0.4×FY 2021: 0.3×FY 2022: 0.1×
FY 2013 5y median 0.2× FY 2022
P/B -0.2×
FY 2013: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 0.2×FY 2022: -0.2×
FY 2013 5y median 0.1× FY 2022
P/FCF -0.0×
FY 2013: -0.1×FY 2014: -0.1×FY 2015: -0.1×FY 2016: -0.0×FY 2017: -0.0×FY 2018: -0.0×FY 2019: -0.0×FY 2020: -0.1×FY 2021: -0.0×FY 2022: -0.0×
FY 2013 5y median -0.0× FY 2022
EV/EBITDA -0.2×
FY 2013: 1.3×FY 2014: 1.8×FY 2015: 2.7×FY 2016: 0.5×FY 2017: -0.5×FY 2018: -0.5×FY 2019: -0.9×FY 2020: -0.5×FY 2021: -0.5×FY 2022: -0.2×
FY 2013 5y median -0.5× FY 2022
EV/Sales 1.8×
FY 2013: -55.7×FY 2014: -14.9×FY 2015: -5.8×FY 2016: -4.0×FY 2017: -0.1×FY 2018: 3.2×FY 2019: 8.8×FY 2020: 3.2×FY 2021: 4.1×FY 2022: 1.8×
FY 2013 5y median 3.2× FY 2022
FCF Yield -8277.3%
FY 2013: -1429.5%FY 2014: -1089.4%FY 2015: -1423.9%FY 2016: -3150.9%FY 2017: -4156.4%FY 2018: -5219.1%FY 2019: -3883.4%FY 2020: -1256.7%FY 2021: -2120.8%FY 2022: -8277.3%
FY 2013 5y median -3883.4% FY 2022

Profitability

Gross Margin 46.8%
FY 2013: 99.0%FY 2014: 46.6%FY 2015: 57.5%FY 2016: 54.7%FY 2017: 92.7%FY 2018: 52.5%FY 2019: 61.1%FY 2020: 75.1%FY 2021: 75.4%FY 2022: 46.8%
FY 2013 5y median 61.1% FY 2022
Operating Margin -802.6%
FY 2013: -4708.9%FY 2014: -908.3%FY 2015: -1612.3%FY 2016: -734.8%FY 2017: 34.5%FY 2018: -610.9%FY 2019: -621.0%FY 2020: -504.0%FY 2021: -695.7%FY 2022: -802.6%
FY 2013 5y median -621.0% FY 2022
Net Margin -911.6%
FY 2013: -4761.8%FY 2014: -906.1%FY 2015: -998.1%FY 2016: -747.3%FY 2017: 6.0%FY 2018: -960.4%FY 2019: -1142.5%FY 2020: -746.4%FY 2021: -810.9%FY 2022: -911.6%
FY 2013 5y median -911.6% FY 2022
ROE 3079.0%
FY 2013: -32.8%FY 2014: -31.9%FY 2015: -31.6%FY 2016: -76.1%FY 2017: 4.5%FY 2018: -97.2%FY 2019: -456.9%FY 2020: -180.7%FY 2021: -544.8%FY 2022: 3079.0%
FY 2013 5y median -180.7% FY 2022
ROIC -286.8%
FY 2013: -24.8%FY 2014: -24.5%FY 2015: -23.3%FY 2016: -18.1%FY 2017: 13.1%FY 2018: -20.2%FY 2019: -40.2%FY 2020: -43.0%FY 2021: -57.0%FY 2022: -286.8%
FY 2013 5y median -43.0% FY 2022
ROA -121.1%
FY 2013: -23.7%FY 2014: -24.5%FY 2015: -13.3%FY 2016: -15.2%FY 2017: 1.9%FY 2018: -30.2%FY 2019: -64.4%FY 2020: -55.7%FY 2021: -61.7%FY 2022: -121.1%
FY 2013 5y median -61.7% FY 2022

Growth (YoY)

Revenue 18.8%
FY 2013: -21.2%FY 2014: 731.3%FY 2015: 20.0%FY 2016: 77.6%FY 2017: 1762.8%FY 2018: -86.0%FY 2019: 48.3%FY 2020: 27.2%FY 2021: 32.3%FY 2022: 18.8%
FY 2013 FY 2022
Operating Income -37.0%
FY 2013: -346.5%FY 2014: -60.3%FY 2015: -113.0%FY 2016: 19.1%FY 2017: 187.4%FY 2018: -347.4%FY 2019: -50.7%FY 2020: -3.3%FY 2021: -82.6%FY 2022: -37.0%
FY 2013 FY 2022
EPS (diluted) 6.2%
FY 2013: -247.6%FY 2014: 11.0%FY 2015: 4.6%FY 2016: 2.4%FY 2017: 110.7%FY 2018: -1576.9%FY 2019: -33.3%FY 2020: 49.2%FY 2021: -12.3%FY 2022: 6.2%
FY 2013 FY 2022
Free Cash Flow -5.8%
FY 2013: -300.9%FY 2014: -68.5%FY 2015: -55.9%FY 2016: -69.9%FY 2017: -41.7%FY 2018: -20.7%FY 2019: -38.7%FY 2020: -6.9%FY 2021: -47.5%FY 2022: -5.8%
FY 2013 FY 2022

Financial Health

Current Ratio 0.3×
FY 2013: 6.0×FY 2014: 7.7×FY 2015: 4.6×FY 2016: 1.2×FY 2017: 0.4×FY 2018: 2.9×FY 2019: 0.6×FY 2020: 0.9×FY 2021: 1.2×FY 2022: 0.3×
FY 2013 5y median 0.9× FY 2022
Quick Ratio 0.3×
FY 2013: 6.0×FY 2014: 7.7×FY 2015: 4.6×FY 2016: 1.2×FY 2017: 0.4×FY 2018: 2.9×FY 2019: 0.6×FY 2020: 0.9×FY 2021: 1.2×FY 2022: 0.3×
FY 2013 5y median 0.9× FY 2022
Debt / Equity -7.2×
FY 2013: 0.1×FY 2014: 0.1×FY 2015: 0.1×FY 2016: 0.6×FY 2017: 0.0×FY 2018: 1.1×FY 2019: 3.7×FY 2020: 1.0×FY 2021: 3.0×FY 2022: -7.2×
FY 2013 5y median 1.1× FY 2022
Net Debt / EBITDA -0.2×
FY 2013: 1.3×FY 2014: 1.9×FY 2015: 3.1×FY 2016: 0.6×FY 2017: -0.6×FY 2018: -0.4×FY 2019: -0.9×FY 2020: -0.4×FY 2021: -0.5×FY 2022: -0.2×
FY 2013 5y median -0.4× FY 2022
Interest Coverage -58.8×
FY 2013: -85.6×FY 2014: -21.3×FY 2015: -44.8×FY 2016: -37.2×FY 2017: 10.5×FY 2018: -2.2×FY 2019: -5.4×FY 2020: -10.0×FY 2021: -36.0×FY 2022: -58.8×
FY 2013 5y median -10.0× FY 2022

Dividends

Dividend Yield 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2013 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2013 5y median 0.0% FY 2022

Annual · latest fiscal year ends 2022-12-31